Vagal stimulation for anti-embolic therapy
US7885711B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Jun 10, 2004 |
| Grant date | Feb 8, 2011 |
| Priority date | — |
| Expiry date | Jun 27, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/395
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Apparatus (20) for treating a subject (30) suffering from spontaneous atrial fibrillation includes an electrode device (22), adapted to be coupled to a site of the subject (30) selected from the list consisting of: a vagus nerve (24) of the subject (30), an epicardial fat pad of the subject (30), a pulmonary vein of the subject (30), a carotid artery of the subject (30), a carotid sinus of the subject (30), a vena cava vein of the subject (30), and an internal jugular vein of the subject (30), and a control unit (32), adapted to drive the electrode device (22) to apply an electrical current to the site, and to configure the current to maintain the spontaneous AF for at least about 24 hours, so as to modify blood flow within the atria and reduce risk of thromboembolic events.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.